Results 81 to 90 of about 1,665 (152)
Metabolic rhythm abnormalities in mice lacking VIP-VPAC2signaling
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008 The circadian pacemaker in the suprachiasmatic nuclei (SCN) controls endogenous near 24-h physiological and behavioral rhythms in metabolism, neuroendocrine function, and locomotor activity. Recently, we showed that vasoactive intestinal polypeptide (VIP) and its receptor, VPAC2are critical to the intercellular communication between individual SCN ...
Bechtold, David A. +3 more
openaire +3 more sources
Distinct VIP and PACAP Functions in the Distal Nerve Stump During Peripheral Nerve Regeneration
Frontiers in Neuroscience, 2019 Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylyl Cyclase Activating Peptide (PACAP) are regeneration-associated neuropeptides, which are up-regulated by neurons following peripheral nerve injury.
Patricia K. Woodley +7 more
doaj +1 more source
PACAP and its receptors in cranial arteries and mast cells
The Journal of Headache and Pain, 2018 Background In migraineurs pituitary adenylate cyclase activating peptide1–38 (PACAP1–38) is a potent migraine provoking substance and the accompanying long lasting flushing suggests degranulation of mast cells.
Inger Jansen-Olesen +1 more
doaj +1 more source
VPAC2 And/Or PAC1 Receptors Interact with NOS during Heat Stress in Humans
The FASEB Journal, 2010 VPAC2 and/or PAC1 receptors are implicated in cutaneous active vasodilation(AVD) during heat stress(HS). Nitric oxide(NO) from NOS also plays important roles in HS in humans. We hypothesized that NO and VPAC2/PAC1 interact in AVD during HS.
Joan L Zhao +3 more
openaire +1 more source
PACAP and its role in primary headaches
The Journal of Headache and Pain, 2018 Pituitary adenylate cyclase-activating peptide (PACAP) is a neuropeptide implicated in a wide range of functions, such as nociception and in primary headaches.
Lars Edvinsson +3 more
doaj +1 more source
Data from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer
<div>Abstract<p>Pancreatic ductal adenocarcinoma (PDAC) harbors a complex tumor microenvironment, and cross-talk among cells in the tumor microenvironment can contribute to drug resistance and relapse. Vasoactive intestinal peptide (VIP) is overexpressed in PDAC, and VIP receptors expressed on T cells are a targetable pathway that ...
Edmund K. Waller +10 more
openaire +1 more source
International Journal of Nanomedicine, 2017 Shao-Jun Zhao,1,2,* De-Hua Wang,1,2 Yan-Wei Li,1,2 Lei Han,1,2 Xing Xiao,1,2 Min Ma,3,* David Chi-Cheong Wan,4 An Hong,1,2 Yi Ma1,2 1Institute of Biomedicine, Department of Cellular Biology, Jinan University, 2National Engineering Research Center of ...
Zhao SJ +8 more
doaj
Abundant Expression of Vasoactive Intestinal Polypeptide Receptor VPAC2 mRNA in Human Skin [PDF]
Journal of Investigative Dermatology, 2001 Fischer, Tanja C. +7 more
openaire +3 more sources
Figure S2 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer
<p>Supplementary Figure</p>
Edmund K. Waller +10 more
openaire +1 more source
Figure S6 from VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer
<p>Supplementary Figure</p>
Edmund K. Waller +10 more
openaire +1 more source